Atlas Trials

Allogeneic CARCIK-CD19 in Adults/Pediatric B-cell NHL or Chronic Lymphocytic Leukemia

Clinical trial NCT05869279 · RECRUITING

Trial details

NCT number
NCT05869279
Sponsor
Fondazione Matilde Tettamanti Menotti De Marchi Onlus
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
B-cell NHLCLL
Start date
2023-12-01
Primary completion
2026-09-01
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.